Daniel Burge
- Rheumatology top 0.2%
- Systemic Lupus Erythematosus Research 7
- Rheumatoid Arthritis Research and Therapies 6
- Hematology top 0.5%
- Autoimmune and Inflammatory Disorders Research 4
- Immunology top 1%
- Psoriasis: Treatment and Pathogenesis 8
- Immunodeficiency and Autoimmune Disorders 2
- Dermatology top 1%
- Genetics top 5%
-
- Monoclonal and Polyclonal Antibodies Research 5
-
- Autoimmune Bullous Skin Diseases 4
-
- Pharmaceutical studies and practices 4
- Co-authors
- Joel M. KremerMichael E. WeinblattKen J. BulpittBarbara FinckRoy FleischmannM. LangeArthur D. BankhurstPhilip J. Mease
- Cited by
- RheumatologyHematologyImmunology
- Journals
- Journal of the American Academy of Dermatology (3 papers)Annals of the Rheumatic Diseases (2 papers)The Journal of Immunology (1 paper)
- Partner nations
- United StatesGermanyBelgium
In The Last Decade
Daniel Burge
22 papers receiving 3.7k citations
Hit Papers
Peers
Comparison fields: 5 of 98
- Rheumatology 2.6k
- Hematology 1.5k
- Immunology 1.6k
- Dermatology 355
- Genetics 344
Countries citing papers authored by Daniel Burge
This map shows the geographic impact of Daniel Burge's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Burge with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Burge more than expected).
Fields of papers citing papers by Daniel Burge
This network shows the impact of papers produced by Daniel Burge. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Burge. The network helps show where Daniel Burge may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Daniel Burge, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 8 | |
| 2 | 2020 | 46 | |
| 3 | 2019 | 7 | |
| 4 | 2018 | 101 | |
| 5 | 2018 | 121 | |
| 6 | 2018 | 1 | |
| 7 | 2017 | 1 | |
| 8 | 2017 | 1 | |
| 9 | 2017 | 0 | |
| 10 | 2016 | 33 | |
| 11 | 2016 | 1 | |
| 12 | 2008 | 19 | |
| 13 | 2004 | 227 | |
| 14 | Pneumococcal vaccine response in psoriatic arthritis patients during treatment with etanercept. | 2004 | 110 |
| 15 | 2003 | 182 | |
| 16 | 2003 | 85 | |
| 17 | Long-term safety and efficacy of etanercept in patients with rheumatoid arthritis. | 2001 | 154 |
| 18 | Etanercept in the treatment of psoriatic arthritis and psoriasis: a randomised trialbreakdown → | 2000 | 1111 |
| 19 | A Trial of Etanercept, a Recombinant Tumor Necrosis Factor Receptor:Fc Fusion Protein, in Patients with Rheumatoid Arthritis Receiving Methotrexatebreakdown → | 1999 | 1612 |
| 20 | Pheochromocytoma in a child. | 1961 | 1 |
About Daniel Burge
Daniel Burge is a scholar working on Rheumatology, Immunology and Hematology, having authored 23 papers that have together received 3.9k indexed citations. Recurring topics across this work include Psoriasis: Treatment and Pathogenesis (8 papers), Systemic Lupus Erythematosus Research (7 papers), Rheumatoid Arthritis Research and Therapies (6 papers), Monoclonal and Polyclonal Antibodies Research (5 papers), Autoimmune Bullous Skin Diseases (4 papers), Autoimmune and Inflammatory Disorders Research (4 papers), Pharmaceutical studies and practices (4 papers) and Immunodeficiency and Autoimmune Disorders (2 papers). The work is most often cited by research in Rheumatology (2.6k citations), Hematology (1.5k citations) and Immunology (1.6k citations). Daniel Burge has collaborated with scholars based in United States, Germany and Belgium. Frequent co-authors include Joel M. Kremer, Michael E. Weinblatt, Ken J. Bulpitt, Barbara Finck, Roy Fleischmann, M. Lange, Arthur D. Bankhurst, Philip J. Mease, James M. Metz and Ann VanderStoep. Their work appears in journals such as Journal of the American Academy of Dermatology, Annals of the Rheumatic Diseases, The Journal of Immunology, New England Journal of Medicine and The Lancet.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.